Opportunity ID: 350505
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | CDC-RFA-GH-24-0097 |
Funding Opportunity Title: | Strengthening Laboratory Capacity and Quality for HIV Diagnosis, Care, Treatment, and Monitoring in Malawi under the President’s Emergency Plan for AIDS Relief (PEPFAR) |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | |
Funding Instrument Type: | Cooperative Agreement |
Category of Funding Activity: | Health |
Category Explanation: | |
Expected Number of Awards: | 2 |
CFDA Number(s): | 93.067 — Global AIDS |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 1 |
Posted Date: | Nov 21, 2023 |
Last Updated Date: | Nov 21, 2023 |
Original Closing Date for Applications: | Feb 04, 2024 Electronically submitted applications must be submitted no later than 11:59 pm ET on the listed application due date. |
Current Closing Date for Applications: | Feb 04, 2024 Electronically submitted applications must be submitted no later than 11:59 pm ET on the listed application due date. |
Archive Date: | Feb 24, 2025 |
Estimated Total Program Funding: | $ 0 |
Award Ceiling: | $0 |
Award Floor: | $0 |
Eligibility
Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
Additional Information on Eligibility: |
Additional Information
Agency Name: | Centers for Disease Control – CGH |
Description: | The Award Ceiling for Year 1 is 0 (none). CDC anticipates an Approximate Total Fiscal Year Funding amount of $8,375,000 for Year 1, subject to the availability of funds.As Malawi strives to reach HIV epidemic control, there is a need to improve and sustain achievements in the national laboratory systems. Technical assistance (TA) to the Ministry of Health (MOH) will ensure universal diagnostics access and address public health system gaps. For sustainability, MOH’s public health laboratory capabilities will be strengthened for governance and ownership, National Reference Laboratories (NRL) capacity will be built for surveillance and outbreak responses, and the HIV laboratory program will be integrated into broader disease areas. Priorities include scaling up patient-centered approaches to identify and address challenges of low viral load coverage (VLC) and suppression in different age groups and populations, point of care testing (POCT) laboratories for integrated multi-disease tests, and rapid testing continuous quality improvement (RTCQI) to achieve national certification. Other priorities include improving access for advanced HIV disease (AHD) and pre-exposure prophylaxis (PrEP) tests, conducting regular diagnostic network optimization to ensure efficiencies and testing accessibility, increasing utilization of high throughput instruments in conventional molecular laboratories to improve VLC, improving biosafety and waste management, preparing additional laboratories for International Organization for Standardization (ISO) accreditations, and extending the external quality assessment (EQA) program to multiple testing parameters. |
Link to Additional Information: | |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact: Emily Dale
pepfarfoas@cdc.gov |
Foa_Content_of_CDC-RFA-GH-24-0097